This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Oct 20;73(8):1548.

doi: 10.1093/cid/ciab661.

Letter to the Editor

Courtney J Baus¹, Lucas T Schulz¹, Alexander J Lepak², Nasia Safdar²

Affiliations

Affiliations

¹ University of Wisconsin Health, Madison, Wisconsin, USA.
² University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

PMID: 34320158
DOI: 10.1093/cid/ciab661

Comment

Letter to the Editor

Courtney J Baus et al. Clin Infect Dis. 2021.

. 2021 Oct 20;73(8):1548.

doi: 10.1093/cid/ciab661.

Authors

Courtney J Baus¹, Lucas T Schulz¹, Alexander J Lepak², Nasia Safdar²

Affiliations

¹ University of Wisconsin Health, Madison, Wisconsin, USA.
² University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

PMID: 34320158
DOI: 10.1093/cid/ciab661

No abstract available

PubMed Disclaimer

Comment on

Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
Maziade PJ, Ship N, Sniffen JC, Goldstein EJC. Maziade PJ, et al. Clin Infect Dis. 2021 Oct 20;73(8):1524-1527. doi: 10.1093/cid/ciab414. Clin Infect Dis. 2021. PMID: 33966076 Free PMC article.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems